DMK PHARMACEUTICALS CORPORATION: cashflow_financing
| Value | {"amount": 285000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-09-30 |
| Status | current |
| Entity | DMK PHARMACEUTICALS CORPORATION |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2fdf87a2-d677-4069-92a6-bed7c0059944
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001387131-22-011400 · Open the official SEC filing →Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000887247/cashflow-financing/2022-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2fdf87a2-d677-4069-92a6-bed7c0059944
History
- no predecessors — first report